What they were paid
Protalix BioTherapeutics Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $45,000 | — | $26,708 | $0 | $71,708 |
| FY2024 | $45,000 | $0 | $0 | $0 | $45,000 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Protalix BioTherapeutics, Inc. DEF 14A filed April 30, 2026, accession 0001104659-26-053016, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Protalix BioTherapeutics, Inc. filed document, accession 0001104659-26-053016. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2026.
That is Amos Bar Shalev’s FY2025 figure, as filed. The FY2026 figure the day it is filed: one email, nothing else.
Saved. One email when Amos Bar Shalev’s next annual disclosure lands here, with the figure.
One email when Amos Bar Shalev’s next annual disclosure is on this page, with the figure. Nothing else is sent.
Get the Protalix BioTherapeutics Board Governance Report
$71,708 Amos Bar Shalev, FY2025 total director compensation
$499
The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.
Data as of April 30, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
How this board is paid
company policy · FY2025Protalix BioTherapeutics pays directors a $45,000 cash retainer.
Committees
FY2025 · as the proxy prints themAudit · Compensation (Chair) · Nominating/Governance (Chair)
The rest of the Protalix BioTherapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Aharon Schwartz, Ph.D | Independent Director | $71,708 |
| Christian Elze | Director | $20,076 |
| Dror Bashan | Director | — |
| Eliot Richard Forster, Ph.D | Chair of the Board | $99,575 |
| Gwen A. Melincoff | Independent Director | $71,708 |
| Pol F. Boudes, M.D | Independent Director | $71,708 |
| Shmuel "Muli" Ben Zvi, Ph.D | Independent Director | $71,341 |
The full Protalix BioTherapeutics compensation record
free company briefThis page is one director within Protalix BioTherapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Peer companies
named in the Protalix BioTherapeutics proxy · each links to its own free briefOrder PLX
Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.